Camomy Trial: A Prospective Randomized Clinical Trial To Compare Six-Months Sputum Conversion Rate With A Clarithromycin Or Moxifloxacin Containing Regimen In Patients With AM. Xenopi Pulmonary Infection: intermediate Analysis - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue American Journal of Respiratory and Critical Care Medicine Année : 2016

Camomy Trial: A Prospective Randomized Clinical Trial To Compare Six-Months Sputum Conversion Rate With A Clarithromycin Or Moxifloxacin Containing Regimen In Patients With AM. Xenopi Pulmonary Infection: intermediate Analysis

Fichier non déposé

Dates et versions

hal-03591343 , version 1 (28-02-2022)

Identifiants

  • HAL Id : hal-03591343 , version 1

Citer

Claire Andrejak, N. Veziris, F. -X. Lescure, H. Mal, D. Bouvry, et al.. Camomy Trial: A Prospective Randomized Clinical Trial To Compare Six-Months Sputum Conversion Rate With A Clarithromycin Or Moxifloxacin Containing Regimen In Patients With AM. Xenopi Pulmonary Infection: intermediate Analysis. American Journal of Respiratory and Critical Care Medicine, 2016, 193. ⟨hal-03591343⟩
35 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More